These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10796065)

  • 21. A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.
    Wu Y; Chen K; Shi Z; Wang Q
    Curr Pharm Biotechnol; 2014; 15(8):685-90. PubMed ID: 25051950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin.
    Maggioni P; Di Stefano F; Facchini V; Irato S; Mancuso S; Colombo M; Massobrio M; Melis GB; Crosignani P
    J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
    Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
    Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
    Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
    Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
    Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Meulemans A
    J Antimicrob Chemother; 1985 Dec; 16(6):751-5. PubMed ID: 3867660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.
    Shah PM; Heller A; Fuhr HG; Walther F; Halir S; Schaumann R; Böhme A; Jung B; Köhler A; Lips-Schulte C; Stille W
    Infection; 1996; 24(6):480-4. PubMed ID: 9007599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections].
    Hou F; Wu G; Zheng B
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):589-93. PubMed ID: 11758237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
    Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
    Jin C; Jung I; Ku HJ; Yook J; Kim DH; Kim M; Cho JH; Oh CH
    Toxicology; 1999 Nov; 138(2):59-67. PubMed ID: 10576583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of zinc ions on in vitro susceptibilities of Stenotrophomonas maltophilia to imipenem and meropenem.
    Cooke P; Heritage J; Kerr K; Hawkey PM; Newton KE
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2909-10. PubMed ID: 9124868
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
    Kaneko Y; Yanagihara K; Kuroki M; Ohi H; Kakeya H; Miyazaki Y; Higashiyama Y; Hirakata Y; Tomono K; Kadota JI; Kohno S
    Chemotherapy; 2001 Dec; 47(6):421-9. PubMed ID: 11786657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1991; 37(1):38-42. PubMed ID: 2013240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.
    White RL; Friedrich LV; Manduru M; Mihm LB; Bosso JA
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):39-47. PubMed ID: 11173190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
    Edwards SJ; Emmas CE; Campbell HE
    Curr Med Res Opin; 2005 May; 21(5):785-94. PubMed ID: 15969878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1995 Aug; 36(2):444-6. PubMed ID: 8522478
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
    Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR
    Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.